TRADING UPDATES: Ondine hails Steriwave data; Creightons name change
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More
| Price | 11.75p on 30-04-2026 at 05:00:08 |
|---|---|
| Change | 0.00p 0% |
| Buy | 0.00p |
| Sell | 0.00p |
| Last Trade: | Unknown 1,874,999.00 at 11.75p |
| Day's Volume: | 0 |
| Last Close: | 11.75p |
| Open: | 0.00p |
| ISIN: | CA68234M2058 |
| Day's Range | 0.00p - 0.00p |
| 52wk Range: | 8.00p - 18.25p |
| Market Capitalisation: | £61.05m |
| VWAP: | 0.00p |
| Shares in Issue: | 519.55m |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Ondine Biomed (OBI) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Unknown* | 1,874,999 | 11.75p | OTC Trade |
17:07:44 - 29-Apr-26 |
| Buy* | 50,000 | 12.00p | Ordinary |
16:48:02 - 29-Apr-26 |
| Unknown* | 75,000 | 12.05p | Negotiated Trade |
16:28:00 - 29-Apr-26 |
| Buy* | 10,947 | 11.788p | Ordinary |
15:02:00 - 29-Apr-26 |
| Buy* | 8,474 | 11.80p | Ordinary |
13:49:21 - 29-Apr-26 |
| Unknown* | 100,000 | 11.652p | Ordinary |
13:17:30 - 29-Apr-26 |
| Buy* | 14,945 | 11.83p | Ordinary |
13:01:56 - 29-Apr-26 |
| Buy* | 16,877 | 11.85p | Suspected BUY Trade |
11:46:44 - 29-Apr-26 |
| Sell* | 52 | 11.50p | Ordinary |
11:16:01 - 29-Apr-26 |
| Buy* | 17,633 | 11.87p | Ordinary |
11:01:29 - 29-Apr-26 |
Ondine Biomed (OBI) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 29th Apr 2026 7:00 am | RNS | Result of Fundraise & TVR |
| 28th Apr 2026 5:26 pm | RNS | Proposed c.£5 million (C$9.23 million) Fundraise |
| 27th Apr 2026 7:00 am | RNS-R | ICU Study to be Presented at 2026 CACCN Conference |
| 23rd Apr 2026 7:00 am | RNS | Marked Reduction in SSIs at Ottawa Heart Institute |
| 22nd Apr 2026 7:00 am | RNS-R | Two Abstracts Accepted at World Congress |
| 14th Apr 2026 7:00 am | RNS | Steriwave ICU Study Shows 39.5% Pneumonia Drop |
| 13th Apr 2026 7:00 am | RNS | Business Update |
| 8th Apr 2026 7:08 am | RNS-R | ICU Study Accepted for Publication |
| 24th Mar 2026 4:28 pm | RNS | Holdings in Company |
| 10th Mar 2026 7:00 am | RNS | Ondine Provides Update on US Phase 3 Pivotal Study |